↓ Skip to main content

Development of lentiviral gene therapy for Wiskott Aldrich syndrome

Overview of attention for article published in Expert Opinion on Biological Therapy, January 2008
Altmetric Badge

Mentioned by

wikipedia
3 Wikipedia pages

Readers on

mendeley
42 Mendeley
connotea
1 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Development of lentiviral gene therapy for Wiskott Aldrich syndrome
Published in
Expert Opinion on Biological Therapy, January 2008
DOI 10.1517/14712598.8.2.181
Pubmed ID
Authors

Anne Galy, Maria-Grazia Roncarolo, Adrian J Thrasher

Abstract

Wiskott Aldrich syndrome (WAS) is a rare X-linked primary immunodeficiency. This complex disease is characterised by microthrombocytopenia, recurrent infections, eczema and is associated with a high incidence of autoimmunity and of lymphoid malignancies. WAS is attracting growing attention not only because it highlights the rich cellular and systems biology revolving around cytoskeletal regulation but also because it is candidate for a haematopoietic stem cell gene therapy indication.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Portugal 1 2%
Unknown 40 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 26%
Student > Bachelor 6 14%
Student > Ph. D. Student 6 14%
Student > Master 6 14%
Student > Postgraduate 2 5%
Other 5 12%
Unknown 6 14%
Readers by discipline Count As %
Agricultural and Biological Sciences 12 29%
Medicine and Dentistry 9 21%
Biochemistry, Genetics and Molecular Biology 7 17%
Immunology and Microbiology 6 14%
Philosophy 1 2%
Other 2 5%
Unknown 5 12%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 March 2021.
All research outputs
#7,453,126
of 22,785,242 outputs
Outputs from Expert Opinion on Biological Therapy
#721
of 1,875 outputs
Outputs of similar age
#41,934
of 156,814 outputs
Outputs of similar age from Expert Opinion on Biological Therapy
#5
of 14 outputs
Altmetric has tracked 22,785,242 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,875 research outputs from this source. They receive a mean Attention Score of 4.9. This one is in the 39th percentile – i.e., 39% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 156,814 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.